A Phase 1, Multi-Center, Open-Label Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Sulopenem and Sulopenem Etzadroxil + Probenecid in Adolescent Patients With Bacterial Infection
Latest Information Update: 15 Jun 2022
At a glance
- Drugs Sulopenem (Primary) ; Sulopenem (Primary) ; Probenecid
- Indications Bacterial infections; Intra-abdominal infections; Pyelonephritis; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors Iterum Therapeutics
- 09 Jun 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 11 Jan 2021 New trial record